Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment
Miller, L.M., Mayer, S.C., Berger, D.M., Boschelli, D.H., Boschelli, F., Di, L., Du, X., Dutia, M., Floyd, M.B., Johnson, M., Kenny, C.H., Krishnamurthy, G., Moy, F., Petusky, S., Tkach, D., Torres, N., Wu, B., Xu, W.(2009) Bioorg Med Chem Lett 19: 62-66
- PubMed: 19041240 
- DOI: 10.1016/j.bmcl.2008.11.037
- Primary Citation of Related Structures:  
3F5P - PubMed Abstract: 
Insulin-like growth factor receptor (IGF-1R) is a growth factor receptor tyrosine kinase that acts as a critical mediator of cell proliferation and survival. Inhibitors of this receptor are believed to provide a new target in cancer therapy. We previousl ...